Belgian listed real estate company Aedifica and UK-listed MedicX Fund will be included in the FTSE EPRA/NAREIT Developed Europe Index from 15 March.
Belgian listed real estate company Aedifica and UK-listed MedicX Fund will be included in the FTSE EPRA/NAREIT Developed Europe Index from 15 March.
Both companies qualified for entry during the Index’s March Quarterly Review with an investability weight of 89% and 100% respectively, EPRA said.
Philip Charls, CEO of EPRA, commented: ‘We welcome another set of excellent inclusions to the EPRA Index - they now join the leading club of European property companies.’
The EPRA index is the most widely used investment index for listed real estate. Following these additions, the total number of constituents in the European index stands at 86, representing a free-float market capitalisation of around €104 bn.
